Smartphone-Based SARS-CoV-2 and Variants Detection System using Colorimetric DNAzyme Reaction Triggered by Loop-Mediated Isothermal Amplification (LAMP) with Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Jayeon Song(Korea Research Institute of Bioscience and Biotechnology), Baekdong Cha(Gwangju Institute of Science and Technology), Jeong Moon(Korea Advanced Institute of Science and Technology), Hyowon Jang(Korea Research Institute of Bioscience and Biotechnology), Sun‐Joo Kim(Gyeongsang National University), Jieun Jang(Korea Center for Disease Control and Prevention), Dongeun Yong(Yonsei University), Hyung‐Jun Kwon(Korea Research Institute of Bioscience and Biotechnology), In‐Chul Lee(Korea Research Institute of Bioscience and Biotechnology), Eun‐Kyung Lim(Korea Research Institute of Bioscience and Biotechnology), Juyeon Jung(Korea Research Institute of Bioscience and Biotechnology), Hyun Gyu Park(Korea Advanced Institute of Science and Technology), Taejoon Kang(Korea Research Institute of Bioscience and Biotechnology)
ACS Nano
June 23, 2022
Cited by 97Open Access
Full Text

Abstract

Coronavirus disease (COVID-19) has affected people for over two years. Moreover, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has raised concerns regarding its accurate diagnosis. Here, we report a colorimetric DNAzyme reaction triggered by loop-mediated isothermal amplification (LAMP) with clustered regularly interspaced short palindromic repeats (CRISPR), referred to as DAMPR assay for detecting SARS-CoV-2 and variants genes with attomolar sensitivity within an hour. The CRISPR-associated protein 9 (Cas9) system eliminated false-positive signals of LAMP products, improving the accuracy of DAMPR assay. Further, we fabricated a portable DAMPR assay system using a three-dimensional printing technique and developed a machine learning (ML)-based smartphone application to routinely check diagnostic results of SARS-CoV-2 and variants. Among blind tests of 136 clinical samples, the proposed system successfully diagnosed COVID-19 patients with a clinical sensitivity and specificity of 100% each. More importantly, the D614G (variant-common), T478K (delta-specific), and A67V (omicron-specific) mutations of the SARS-CoV-2 S gene were detected selectively, enabling the diagnosis of 70 SARS-CoV-2 delta or omicron variant patients. The DAMPR assay system is expected to be employed for on-site, rapid, accurate detection of SARS-CoV-2 and its variants gene and employed in the diagnosis of various infectious diseases.


Related Papers

No related papers found

Powered by citation graph analysis